Prolapse Genital
12
3
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Posterior Mesh Fixation at the Levator Ani Level in Apical Pelvic Organ Prolapse
Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery
Comparison of Anterior Vaginal Sacrospinofixation With Laparoscopic Promontofixation for the Treatment of Anterior and Apical Genitourinary Prolapse
Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineorrhaphy ± Transverse Myorrhaphy of the Puborectalis Muscles at 12 Months. (HERA)
iMEA : Comparison of Micro-innervation and Muscle Microstructure of the Anal Levator Muscle Between Patients With Urogenital Prolapse and Those Who Are Asymptomatic
Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment
Clinical Trial of "Magic Gyno" Laser Device
Opioid Use After Urogynecologic Procedures: Using a Predictive Calculator
A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ Prolapse
Total Versus Subtotal Abdominal Hysterectomy at Time of Abdominal Sacrocolpopexy
The Change in Vaginal Axis on MRI After Uterus Preserving Laparoscopic Lateral Mesh Suspension
Comparison of Single Versus Multicenter Outcomes for Pelvic Organ Prolapse Repair Using a Mesh-capturing Device